Skip to main content
SpringerLink
Log in

Studies of the Membrane-Protecting Potential of the Combination of 2-Ethyl-6-Methyl-Hydroxypyridine Succinate and Citicoline

  • Published:
Neuroscience and Behavioral Physiology Aims and scope Submit manuscript

Objectives. To assess changes in the phospholipid composition of blood plasma in patients with chronic cerebrovascular disease using the neuroprotectors 2-ethyl-6-methyl-3-hydroxypyridine succinate (Neurox) and citocoline (Neipilept), which are natural metabolites and participants in metabolic processes in the body, alone and in combination. Materials and methods. A total of 40 patients (18 men, 22 women) aged 54–72 years took part in the study; patients had chronic cerebrovascular disease in exacerbation on the background of hypertensive crisis and/or impairments to cardiac rhythm. Results. Extraction of lipids from patients’ blood cells revealed significant reductions in the quantities of all (total) lipids after completion of treatment in patients receiving Neurox, Neipilept, and complex treatment using both agents. Studies of the quantitative composition of blood cell phospholipids showed that there were no significant changes in patients taking Neurox, while citicoline, alone and in combination with 2-ethyl-6-methyl-3-hydroxypyridine succinate, led to increases in total quantities. Assessment of the qualitative composition of classes of phospholipids in plasma showed no significant changes in patients taking Neurox, while those receiving Neipilept alone and with 2-ethyl-6-methyl-3-hydroxypyridine succinate showed significant increases in plasma phosphatidylcholine. There were no significant changes in phosphatidylinositol, phosphatidylserine, or sphingomyelin contents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. M. A. Moskowitz, E. H. Lo, and C. Iadecola, “The science of stroke: mechanisms in search of treatments,” Neuron, 67, 181–198 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. P. Lipton, “Ischemic cell death in brain neurons,” Physiol. Rev., 79, 1431–1568 (1999).

    Article  CAS  PubMed  Google Scholar 

  3. M. A. Moskowitz, E. H. Lo, and C. Iadecola, “The science of stroke: mechanisms in search of treatments,” Neuron, 67, 181–198 (2010), https://doi.org/10.1016/j.neuron.2010.08.019.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. K. E. Wellen, C. Lu, A. Mancuso, et al., “The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism,” Genes Dev., 24. No. 24, 2784–2799 (2010), https://doi.org/10.1101/gad.1985910.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. R. Bell, D. Burns, T. Okazaki, and Y. Hannun, “Neurobiology of essential fatty adds. Network of signal transduction pathways involving lipids: protein kinase c-dependent and -independent pathways,” Adv. Exp. Med. Biol., 318, 275–282 (1992).

    Article  CAS  PubMed  Google Scholar 

  6. N. Andrieu-Abadie, V. Gouaze, R. Salvayre, and T. Levade, “Ceramide in apoptosis signalling: relationship with oxidative stress,” Free Radic. Biol. Med., 31, No. 6, 717–728 (2001).

    Article  CAS  PubMed  Google Scholar 

  7. N. Andrieu-Abadie and T. Levade, “Sphingomyelin hydrolysis during apoptosis,” Biochim. Biophys. Acta, 1585, No. 2–3), 126–134 (2002).

    Article  CAS  PubMed  Google Scholar 

  8. W. Droge, “Free radicals in the physiological control of cell function,” Physiol. Rev., 82, No. l, 47–95 (2002).

    Article  CAS  PubMed  Google Scholar 

  9. G. J. Ter Horst and J. Korf (eds), Clinical Pharmacology of Cerebral Ischemia, Humana Press, Totowa, NJ (1997).

    Google Scholar 

  10. R. M. Adibhatla and J. F. Hatcher, “Cytidine 5’-diphosphocholine (CDP-choline) in stroke and other CNS disorders,” Neurochem. Res., 30, No. 1, 15–23 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. J. W. Phillis and M. H. O’Regan, “The role of phospholipases, cyclooxygenases, and lipoxygenases in cerebral ischemic/traumatic injuries,” Crit. Rev. Neurobiol., 15, No. 1, 61–90 (2003).

    Article  CAS  PubMed  Google Scholar 

  12. A. M. Rao, J. F. Hatcher, M. S. Kindy, and R. J. Dempsey, “Arachidonic acid and leukotriene C4: role in transient cerebral ischemia of gerbils,” Neurochem. Res., 24. No. 10, 1225–1232 (1999).

    Article  CAS  PubMed  Google Scholar 

  13. P. Sahota and S. I. Savitz, “Investigational therapies for ischemic stroke: neuroprotection and neurorecovery,” Neurotherapeutics, 8, No. 3, 434–451 (2011), https://doi.org/10.1007/s13311-011-0040-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. J. L. Saver, “Target brain: neuroprotection and neurorestoration in ischemic stroke,” Rev. Neurol. Dis., 7, No. 1, 14–21 (2010).

    Google Scholar 

  15. E. Yu. Soloveva, A. N. Karneev, A. V. Chekanov, et al., “The complex use of vinpocetin and 2-ethyl-6-methyl-3-hydroxypyridine succinate in cerebrovascular pathology,” Zh. Nevrol. Psikhiatr., 117, No. 5, 103–108 (2017), https://doi.org/10.17116/jnevro201711751103-108.

    Article  Google Scholar 

  16. G. R. Bartlett, “Phosphorus assay in column chromatography,” J. Biol. Chem., 234, No. 3, 466–468 (1959).

    CAS  PubMed  Google Scholar 

  17. V. I. Svetashev and V. E. Vaskovsky, “A simplifi ed technique for thin-layer microchromatography on lipids,” J. Cromatogr., 67, No. 2, 376–378 (1972).

    Article  CAS  Google Scholar 

  18. V. E. Vaskovsky and E. Y. Kostetsky, “Modifi ed spray for the detection of phospholipids on thin-layer chromatograms,” J. Lipid Res., 9, 396 (1968).

    CAS  PubMed  Google Scholar 

  19. T. Brodniewicz-Proba, “Human plasma fractionation and the impact of new technologies on the use and quality of plasma-derived products,” Blood Rev., 5, 245–257 (1991), https://doi.org/10.1016/0268-960X(91)90016-6.

    Article  CAS  PubMed  Google Scholar 

  20. O. Yu. Rebrova, Statistical Analysis of Medical Data, Media Sfera, Moscow (2006).

  21. M. V. Bilenko, Ischemic and Reperfusional Damage to Organs, Meditsina, Moscow (1989).

  22. J. T. Coyle and P. Puttfarcken, “Oxidative stress, glutamate, and neurodegenerative disorders,” Science, 262, 689–695 (1993), https://doi.org/10.1126/Science.7901908.

    Article  CAS  PubMed  Google Scholar 

  23. Y. Huang, Q. He, and L. Zhan, “The effects of CDP-Choline on the improvement of the successful rate of cardiopulmonary resuscitation and post-resuscitation cardiac function,” Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 25, No. 2, 80–83 (2013), https://doi.org/10.3760/cma.j.issn.2095-4352.2013.02.007.

    Article  CAS  PubMed  Google Scholar 

  24. G. Paragh, E. Kovacs, I. Seres, et al., “Altered signal pathway in granulocytes from patients with hypercholesterolemia,” J. Lipid Res., 40, 1728–1733 (1999).

    CAS  PubMed  Google Scholar 

  25. P. J. Thompson, N. L. A. Misso, M. Passarelli, and M. S. Phillips, “The effect of eicosapentaenoic acid consumption on human neutrophil chemiluminescence,” Lipids, 26, 1223–1226 (1991).

    Article  CAS  PubMed  Google Scholar 

  26. S. Labrouche, G. Freyburger, H. Gin, et al., “Changes in phospholipid composition of blood cell membranes (erythrocyte, platelet, and polymorphonuclear) in different types of diabetes – clinical and biological correlations,” Metabolism, 45, No. 1, 57–71 (1996).

    Article  CAS  PubMed  Google Scholar 

  27. Y. Y. Zhao, H. Miao, X. L. Cheng, and F. Wei, “Lipidomics: Novel insight into the biochemical mechanism of lipid metabolism and dysregulation-associated disease,” Chem. Biol. Interact., 240, 220–38 (2015), https://doi.org/10.1016/j.cbi.2015.09.005.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pirogov Russian National Research Medical University, Russian Ministry of Health, Moscow, Russia

    E. Yu. Solovyeva, A. N. Karneev, A. V. Chekanov, O. A. Baranova, V. A. Shchelkonogov & K. I. Farakhova

  2. Moscow Technological University, Moscow, Russia

    V. A. Shchelkonogov, A. M. Sinebryukhova & G. M. Sorokoumova

Authors
  1. E. Yu. Solovyeva
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. N. Karneev
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. V. Chekanov
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. O. A. Baranova
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. V. A. Shchelkonogov
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. M. Sinebryukhova
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. K. I. Farakhova
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. G. M. Sorokoumova
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. Yu. Solovyeva.

Additional information

Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 118, No. 1, Iss. 1, pp. 18–22, January, 2018.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Solovyeva, E.Y., Karneev, A.N., Chekanov, A.V. et al. Studies of the Membrane-Protecting Potential of the Combination of 2-Ethyl-6-Methyl-Hydroxypyridine Succinate and Citicoline. Neurosci Behav Physi 49, 738–742 (2019). https://doi.org/10.1007/s11055-019-00794-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11055-019-00794-0

Keywords

Search

Navigation